BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25937529)

  • 1. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation.
    Unger JM; Vaidya R; Hershman DL; Minasian LM; Fleury ME
    J Natl Cancer Inst; 2019 Mar; 111(3):245-255. PubMed ID: 30856272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
    Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
    Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
    Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
    Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enrollment of Individuals From Racial and Ethnic Minority Groups in Gynecologic Cancer Precision Oncology Trials.
    Mattei LH; Robb L; Banning K; Polan RM; Cote ML
    Obstet Gynecol; 2022 Oct; 140(4):654-661. PubMed ID: 36075065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
    Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
    Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.
    Unger JM; Hershman DL; Fleury ME; Vaidya R
    JAMA Oncol; 2019 Mar; 5(3):326-333. PubMed ID: 30629092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial participation among ethnic/racial minority and majority patients with advanced cancer: what factors most influence enrollment?
    Jimenez R; Zhang B; Joffe S; Nilsson M; Rivera L; Mutchler J; Lathan C; Paulk ME; Prigerson HG
    J Palliat Med; 2013 Mar; 16(3):256-62. PubMed ID: 23384245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment of patients with lung and colorectal cancers onto clinical trials.
    Fouad MN; Lee JY; Catalano PJ; Vogt TM; Zafar SY; West DW; Simon C; Klabunde CN; Kahn KL; Weeks JC; Kiefe CI
    J Oncol Pract; 2013 Mar; 9(2):e40-7. PubMed ID: 23814523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
    Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
    Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Lee SS; Dinicu AI; Arthurs L; Shields D; Pothuri B; Lightfoot MDS
    Am J Obstet Gynecol; 2024 Jan; 230(1):73.e1-73.e14. PubMed ID: 37751830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing clinical trials: can the multidisciplinary Tumor Board improve participation? A study from an academic women's cancer program.
    Kuroki L; Stuckey A; Hirway P; Raker CA; Bandera CA; DiSilvestro PA; Granai CO; Legare RD; Sakr BJ; Dizon DS
    Gynecol Oncol; 2010 Mar; 116(3):295-300. PubMed ID: 20042225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of physician recommendation on enrollment in the Breast Cancer Chemoprevention Trial.
    Kinney AY; Richards C; Vernon SW; Vogel VG
    Prev Med; 1998; 27(5 Pt 1):713-9. PubMed ID: 9808803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thoracic Radiation Oncology Clinical Trial Accrual and Reasons for Nonenrollment: Results of a Large, Prospective, Multiyear Analysis.
    Mesko S; Ning MS; Lakomy D; Verma V; Chang JY; O'Reilly M; Jeter MD; Gandhi SJ; Lin SH; Nguyen QN; Liao Z; Welsh J; Chen AB; Hahn S; Gomez DR
    Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):897-908. PubMed ID: 32360653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most children with cancer are not enrolled on a clinical trial in Canada: a population-based study.
    Pole JD; Barber R; Bergeron RÉ; Carret AS; Dix D; Kulkarni K; Martineau E; Randall A; Stammers D; Strahlendorf C; Strother DR; Truong TH; Sung L
    BMC Cancer; 2017 Jun; 17(1):402. PubMed ID: 28583094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population-based assessment of specialty physician involvement in cancer clinical trials.
    Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
    J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opinions and expectations of women in the treatment of cervical and uterine cancer in Spain.
    Rodríguez MA; Suess A; Cerdá JC; Carretero ME; Danet A
    Womens Health (Lond); 2011 Nov; 7(6):709-18. PubMed ID: 22040211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority participation in Gynecologic Oncology Group (GOG) Studies.
    Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
    Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.